MicroRNA: A novel target of curcumin in cancer therapy

被引:201
作者
Mirzaei, Hamed [1 ]
Masoudifar, Aria [2 ]
Sahebkar, Amirhossein [3 ]
Zare, Naser [4 ]
Nahand, Javid Sadri [5 ]
Rashidi, Bahman [6 ]
Mehrabian, Emadodin [7 ]
Mohammadi, Mohsen [8 ,9 ]
Mirzaei, Hamid Reza [10 ]
Jaafari, Mahmoud Reza [11 ]
机构
[1] Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, Mashhad, Iran
[2] ACECR, Royan Inst Biotechnol, Cell Sci Res Ctr, Dept Mol Biotechnol, Esfahan, Iran
[3] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran
[4] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[5] Iran Univ Med Sci, Sch Med, Dept Virol, Tehran, Iran
[6] Isfahan Univ Med Sci, Sch Med, Dept Anat Sci & Mol Biol, Esfahan, Iran
[7] Shiraz Univ Med Sci, Sch Med, Shiraz, Iran
[8] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Fac Pharm, Khorramabad, Iran
[9] Lorestan Univ Med Sci, Dept Pharmaceut Biotechnol, Fac Pharm, Khorramabad, Iran
[10] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran 1417613151, Iran
[11] Mashhad Univ Med Sci, Sch Pharm, Nanotechnol Res Ctr, Mashhad 917751365, Iran
关键词
cancer; curcumin; exosome; microRNA; therapy; TO-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; TRANSCRIPTION FACTOR SP1; MULTIDRUG-RESISTANCE; UP-REGULATION; CIRCULATING MICRORNAS; PROMOTES APOPTOSIS; SIGNALING PATHWAY; DRUG-SENSITIVITY; GASTRIC-CANCER;
D O I
10.1002/jcp.26055
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Curcumin is known as a natural dietary polyphenol which is extracted from Curcuma longa L. It has been shown that curcumin has a variety of pharmacological effects such as antioxidant, anti-cancer, anti-inflammatory, and anti-microbial activities. Anti-cancer effects of curcumin are due to targeting of a wide range of cellular and molecular pathways involved in cancer pathogenesis including NF-kB, MAPK, PTEN, P53, and microRNAs (miRNA) network. Multiple lines of evidence have indicated that curcumin exerts its therapeutic effects via regulating miRNA expression (e.g., miR-1, miR-7, miR-9, miR-34a, miR-181, miR-21, and miR-19) which could lead to the regulation of underlying cellular and molecular pathways involved in cancer pathogenesis. Exosomes are one of the important classes of biological vehicles which could be released from various types of cells such as cancer cells and stem cells and could change the behavior of recipient cells. It has been shown that treatment of cancer cells with different dose of curcumin leads to the release of exosomes containing curcumin. These exosomes could induce anti-cancer properties in recipient cells and reduce tumor growth. Hence, exosomes containing curcumin could be applied as powerful tools for cancer treatment. Here, we highlighted various miRNAs which could be affected by curcumin in various types of cancer. Moreover, we highlight exosomes containing curcumin as suitable therapeutic tools in cancer therapy. Curcumin is known as a natural dietary polyphenol which is extracted from Curcuma longa L. It has been shown that curcumin has a variety of pharmacological effects such as antioxidant, anti-cancer, anti-inflammatory, and anti-microbial activities. Anti-cancer effects of curcumin are due to targeting of a wide range of cellular and molecular pathways involved in cancer pathogenesis including NF-kB, MAPK, PTEN, P53, and microRNAs (miRNA) network. Multiple lines of evidence have indicated that curcumin exerts its therapeutic effects via regulating miRNA expression (e.g., miR-1, miR-7, miR-9, miR-34a, miR-181, miR-21, and miR-19) which could lead to the regulation of underlying cellular and molecular pathways involved in cancer pathogenesis. Exosomes are one of the important classes of biological vehicles which could be released from various types of cells such as cancer cells and stem cells and could change the behavior of recipient cells. It has been shown that treatment of cancer cells with different dose of curcumin leads to the release of exosomes containing curcumin. These exosomes could induce anti-cancer properties in recipient cells and reduce tumor growth.
引用
收藏
页码:3004 / 3015
页数:12
相关论文
共 50 条
[41]   HSA-curcumin nanoparticles: a promising substitution for Curcumin as a Cancer chemoprevention and therapy [J].
Zahra Matloubi ;
Zuhair Hassan .
DARU Journal of Pharmaceutical Sciences, 2020, 28 :209-219
[42]   Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer [J].
Tan, Bee Ling ;
Norhaizan, Mohd Esa .
MOLECULES, 2019, 24 (14)
[43]   SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer [J].
Salzman, David W. ;
Weidhaas, Joanne B. .
PHARMACOLOGY & THERAPEUTICS, 2013, 137 (01) :55-63
[44]   The targeting of non-coding RNAs by curcumin: Facts and hopes for cancer therapy [J].
Liu, Yun ;
Sun, Hongmei ;
Makabel, Bolat ;
Cui, Qingbin ;
Li, Jiajun ;
Su, Chaoyue ;
Ashby, Charles R., Jr. ;
Chen, Zhesheng ;
Zhang, Jianye .
ONCOLOGY REPORTS, 2019, 42 (01) :20-34
[45]   MicroRNA: Potential biomarker and target of therapy in acute lung injury [J].
Jiang, Z-F ;
Zhang, L. ;
Shen, J. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2020, 39 (11) :1429-1442
[46]   Frizzled7 as an emerging target for cancer therapy [J].
King, Taj D. ;
Zhang, Wei ;
Suto, Mark J. ;
Li, Yonghe .
CELLULAR SIGNALLING, 2012, 24 (04) :846-851
[47]   Exosomal TRIM3 is a novel marker and therapy target for gastric cancer [J].
Fu, Hailong ;
Yang, Huan ;
Zhang, Xu ;
Wang, Bo ;
Mao, Jiahui ;
Li, Xia ;
Wang, Mei ;
Zhang, Bin ;
Sun, Zixuan ;
Qian, Hui ;
Xu, Wenrong .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37
[48]   Exosomal TRIM3 is a novel marker and therapy target for gastric cancer [J].
Hailong Fu ;
Huan Yang ;
Xu Zhang ;
Bo Wang ;
Jiahui Mao ;
Xia Li ;
Mei Wang ;
Bin Zhang ;
Zixuan Sun ;
Hui Qian ;
Wenrong Xu .
Journal of Experimental & Clinical Cancer Research, 37
[49]   Heparanase as a Target in Cancer Therapy [J].
Masola, Valentina ;
Secchi, Maria Francesca ;
Gambaro, Giovanni ;
Onisto, Maurizio .
CURRENT CANCER DRUG TARGETS, 2014, 14 (03) :286-293
[50]   The cGAS/STING Pathway: A Novel Target for Cancer Therapy [J].
Gan, Yu ;
Li, Xiaoying ;
Han, Shuangze ;
Liang, Qi ;
Ma, Xiaoqian ;
Rong, Pengfei ;
Wang, Wei ;
Li, Wei .
FRONTIERS IN IMMUNOLOGY, 2022, 12